MedTrace Logo

Effectiveness of Technology for Metabolic Diseases Combined Sarcopenia

NCT05476536 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2023-02-08

No results posted yet for this study

Summary

The lifestyle program intervention program focusing on healthy dietary habit and exercise effectively prevents metabolic syndrome, sarcopenia or frailty. Thus, the purpose of this study was to assess the efficacy of intervention program on metabolic syndrome subjects in Taiwan.

Conditions

  • Metabolic Disease

Interventions

BEHAVIORAL

self-management skills and healthy technology APP

self-management skills and healthy technology APP

Sponsors & Collaborators

  • Chang Gung Memorial Hospital

    collaborator OTHER

  • Ministry of Science and Technology, Taiwan

    collaborator OTHER_GOV

  • Chang Gung University of Science and Technology

    lead OTHER

Principal Investigators

  • Shu-Hung Chang, Ph.D · Chang Gung University of Science and Technology

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-02-15
Primary Completion
2023-07-31
Completion
2023-07-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05476536 on ClinicalTrials.gov